AKYNZEO is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Helsinn Therapeutics (u.s.), Inc.. The primary component is Fosnetupitant; Palonosetron Hydrochloride.
Product ID | 69639-102_13e49207-5307-4add-ab8d-a5bdc8138704 |
NDC | 69639-102 |
Product Type | Human Prescription Drug |
Proprietary Name | AKYNZEO |
Generic Name | Fosnetupitant And Palonosetron |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2018-04-20 |
Marketing Category | NDA / NDA |
Application Number | NDA210493 |
Labeler Name | Helsinn Therapeutics (U.S.), Inc. |
Substance Name | FOSNETUPITANT; PALONOSETRON HYDROCHLORIDE |
Active Ingredient Strength | 260 mg/1; mg/1 |
Pharm Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-04-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA210493 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-04-20 |
Ingredient | Strength |
---|---|
FOSNETUPITANT | 260 mg/1 |
SPL SET ID: | 8e47618e-af46-4d82-94e8-1507c042252d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
69639-101 | AKYNZEO | Netupitant and Palonosetron |
69639-102 | AKYNZEO | Fosnetupitant and Palonosetron |
69639-105 | AKYNZEO | Fosnetupitant and Palonosetron |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AKYNZEO 85264083 4066299 Live/Registered |
Helsinn Healthcare S.A. 2011-03-11 |
AKYNZEO 79140820 4595036 Live/Registered |
Helsinn Healthcare SA 2013-10-17 |